Australian government rejects Cosette's proposed Mayne Pharma buyout, citing 'national interest'

Fierce Pharma·Nov 21

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

The Australian government has rejected a proposed buyout of Mayne Pharma by Cosette, citing national interest. The deal's value is uncertain, with reported figures ranging from $387.2 million to $672 million. The rejection has reportedly led to a significant decline in Mayne Pharma's stock and threats from Cosette to scrap the deal.

Full coverage

Fetching the latest headlines…

Australian government rejects Cosette's proposed Mayne Pharma buyout, citing 'national interest'

Full coverage

Australia Blocks U.S.-Based Cosette’s $387.2 Million Takeover of Mayne Pharma

Australian govt objects to Mayne Pharma takeover by Cosette

Mayne Pharma slumps 30% as Cosette threatens to scrap $432 million deal

Inside Mayne Pharma suitor’s battle to sink Project Crocodile

Chalmers risks falling for bluff over a case of buyers’ remorse

NSW Supreme Court reaffirms high threshold for material adverse change in M&A

Shareholders, lawyers slam move to kill Mayne Pharma takeover bid

South Australia asks FIRB to block Cosette’s $672m Mayne takeover bid